Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer

Human Pathology

Volumn 43, Issue 4, 2012, Pages 577-584

  Merikallio, Heta ^a,b   Pääkkö, Paavo ^a   Kinnula, Vuokko L ^c   Harju, Terttu ^a,b   Soini, Ylermi ^d  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antioxidant; Carcinoma; Lung; Nrf2; PARK 7; Sulfiredoxin

Indexed keywords

ANTIBODY; CYTOSTATIC AGENT; DJ 1 PROTEIN; ENZYME; SULFIREDOXIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ADENOSQUAMOUS CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PROTEIN EXPRESSION; SMOKING; SURVIVAL TIME; TREATMENT OUTCOME;

ANTIBODIES; ANTIOXIDANTS; CARCINOMA; CELL NUCLEUS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; NF-E2-RELATED FACTOR 2; ONCOGENE PROTEINS; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PARAFFIN EMBEDDING; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 84858158377     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.05.024     Document Type: Article

References (35)

1. K. Itoh, J. Mimura, and M. Yamamoto Discovery of the negative regulator of Nrf2, Keap1: a historical overview Antioxid Redox Signal 13 2010 1665 1678
2. R. Hu, C.L. Saw, R. Yu, and A.N. Kong Regulation of Nrf2 signaling for cancer chemoprevention: antioxidant coupled with anti-inflammatory Antioxid Redox Signal 13 2010 1679 1698
3. N.F. Villeneuve, A. Lau, and D.D. Zhang Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases Antioxid Redox Signal 13 2010 1699 1712
4. J.D. Hayes, M. McMahon, and S. Chowdhry Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway Antioxid Redox Signal 13 2010 1713 1748
5. D.D. Zhang The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer Antioxid Redox Signal 13 2010 1623 1626
6. C.M. Clements, R.S. McNally, and B.J. Conti DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proc Natl Acad Sci U S A 103 2006 15091 15096 (Pubitemid 44583169)
7. T. Yokota, K. Sugawara, and K. Ito Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition Biochem Biophys Res Commun 312 2003 1342 1348 (Pubitemid 37490964)
8. S.J. Mullett, R.L. Hamilton, and D.A. Hinkle DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age Neuropathology 9 2009 125 131
9. G. Krebiehl, S. Ruckerbauer, and L.F. Burbulla Basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1 PLoS One 2010 5e9367
10. H. Liu, M. Wang, M. Li, and D. Wang Expression and role of DJ-1 in leukemia Biochem Biophys Res Commun 375 2008 477 483
11. S. Vasseur, S. Afzal, and J. Tardivel-Lacombe DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses Proc Natl Acad Sci U S A 106 2009 1111 1116
12. R.T. Sitaram, C.J. Cairney, and P. Grabowski The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma Int J Cancer 125 2009 783 790
13. L. Gu, T. Cui, and C. Fan Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress Biochem Biophys Res Commun 383 2009 469 474
14. J. Fan, H. Ren, and N. Jia DJ-1 decreases Bax expression through repressing P53 transcriptional activity J Biol Chem 283 2008 4022 4030
15. A.G. Cox, C.C. Winterbourn, and B.M.l. Hampton Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signaling Biochem J 425 2010 313 325
16. S.G. Rhee, K.S. Yang, and S.W. Kang Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification Antioxid Redox Signal 7 2005 619 626 (Pubitemid 40563199)
17. H.A. Woo, W. Jeong, and T.S. Chang Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins J Biol Chem 280 2005 3125 3128 (Pubitemid 40223772)
18. F.X. Soriano, P. Baxter, and L.M. Murray Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin Mol Cell 27 2009 279 282
19. A.G. Planson, G. Palais, and K. Abbas Sulfiredoxin protects mice from lipopolysaccharide-induced endotoxic shock Antioxid Redox Signal 14 2011 2071 2080
20. Q. Wei, H. Jiang, C.P. Matthews, and N.H. Colburn Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies Proc Natl Acad Sci U S A 105 2008 19738 19743
21. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris Tumours of the lung, pleura, thymus and heart. Pathology & genetics. WHO classification of tumours 2004 IARC Press Lyon
22. W. Mazur, P. Lindholm, and K. Vuorinen Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia APMIS 118 2010 703 712
23. J.C. Tharappel, J. Cholewa, and P. Espandiari Effects of cigarette smoke on the activation of oxidative stress-related transcription factors in female A/J mouse lung J Toxicol Environ Health A 73 2010 1288 1297
24. P. Karihtala, and Y. Soini Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies APMIS 115 2007 81 103 (Pubitemid 46208084)
25. Y.R. Kim, J.E. Oh, and M.S. Kim Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin J Pathol 220 2010 446 451
26. J. Wang, M. Zhang, and L. Zhang Correlation of Nrf2,HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival J Surg Res 164 2010 e99 105
27. L.M. Solis, C. Behrens, and W. Dong Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features Clin Cancer Res 16 2010 3743 3753
28. J. van Horssen, J.A. Drexhage, and T. Flor Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions Free Radic Biol Med 49 2010 1283 1289
29. X.L. Zhu, Z.F. Wang, and W.B. Lei DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma Cancer Sci 101 2010 1320 1325
30. M. Tian, Y.Z. Cui, and G.H. Song Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients BMC Cancer 8 2008 241
31. R.H. Kim, M. Peters, and Y. Jang DJ-1, a novel regulator of the tumor suppressor PTEN Cancer Cell 7 2005 263 273 (Pubitemid 40568685)
32. R.S. McNally, B.K. Davis, and C.M. Clements DJ-1 enhances cell survival through the binding of cezanne, a negative regulator of NF-{kappa}B J Biol Chem 286 2011 4098 4106
33. B. Zhang, Y. Wang, and Y. Su Peroxiredoxins, a novel target in cancer radiotherapy Cancer Lett 286 2009 154 160
34. V.L. Kinnula, S. Lehtonen, and R. Sormunen Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma J Pathol 196 2002 316 323 (Pubitemid 34189421)
35. A. Singh, G. Ling, and A.N. Suhasini Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs Free Radic Biol Med 46 2009 376 386